Medical and Pharmaceutical
It will be worth over US$1.3 billion more than its current valuation by 2029, The Business Research Company says
Hi, what are you looking for?
Mugglehead Investment Magazine
All posts tagged "Roche Holdings"
Medical and Pharmaceutical
Innovent Biologics will receive up to US$1 billion in milestone payments and royalties
Health & Wellness
Poseida's proprietary non-viral gene engineering technology has delivered promising early clinical results
